FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224043451> ?p ?o ?g. }

• W4224043451 endingPage "2924" @default.
• W4224043451 startingPage "2915" @default.
• W4224043451 abstract "CoronaVac was administered as the primary COVID-19 vaccine for Thai health care workers (HCWs) in early 2021 in response to the epidemic of new variants. This study aimed to evaluate the dynamic of humoral immune response as well as the short-term side effects resulting from the booster dose of BNT162b2 following completion of a CoronaVac double-dose in Thai HCWs. This study was conducted at a teaching hospital in Northern Thailand during August and September 2021. The participants were 50 HCWs who were vaccinated with 2 doses of CoronaVac and were scheduled to receive a booster dose of BNT162b2. Anti-SARS-CoV-2 IgG antibodies levels and short-term side effects were assessed. The anti-RBD level was determined using Architect SARS-CoV-2 IgG II Quant (Abbott). Of the 50 participants, 37 were female. The median age was 33.0 years old. The average time between the second CoronaVac shot and the BNT162b2 booster shot was 81.7 days (SD = 25.0). The median anti-SARS-CoV-2 IgG antibody level on booster vaccination date, as well as day 14, and day 28 after the booster were 335.5 AU/ml, 31,613.5 AU/ml, and 20,311.9 AU/ml, respectively. Fourteen days after the booster, 94% of participants had anti-SARS-CoV-2 IgG antibody levels higher than 50.0 AU/ml. Being female, higher log anti-SARS-CoV-2 IgG antibodies prior to booster vaccination, and longer interval between the second shot and the booster shot were found to be significantly associated with higher levels of anti-SARS-CoV-2 IgG antibodies at both day 14 and day 28 after the booster. There were no reports of serious adverse events. A booster dose of BNT162B2 promoted a high level of anti-SARS-CoV-2 IgG antibodies among HCWs who received 2 doses of CoronaVac. The time between the second CoronaVac shot and the booster shot should be at least three months. There were no severe adverse effects observed." @default.
• W4224043451 created "2022-04-19" @default.
• W4224043451 creator A5001937330 @default.
• W4224043451 creator A5012424809 @default.
• W4224043451 creator A5017174845 @default.
• W4224043451 creator A5032416500 @default.
• W4224043451 creator A5032529136 @default.
• W4224043451 creator A5044653763 @default.
• W4224043451 creator A5052451601 @default.
• W4224043451 creator A5060687579 @default.
• W4224043451 creator A5071377696 @default.
• W4224043451 creator A5078978544 @default.
• W4224043451 date "2022-05-01" @default.
• W4224043451 modified "2023-09-29" @default.
• W4224043451 title "Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers" @default.
• W4224043451 cites W2045019335 @default.
• W4224043451 cites W2045552126 @default.
• W4224043451 cites W3102328262 @default.
• W4224043451 cites W3111255098 @default.
• W4224043451 cites W3118121970 @default.
• W4224043451 cites W3125591068 @default.
• W4224043451 cites W3127409188 @default.
• W4224043451 cites W3129633728 @default.
• W4224043451 cites W3137970801 @default.
• W4224043451 cites W3140226555 @default.
• W4224043451 cites W3152102956 @default.
• W4224043451 cites W3157162195 @default.
• W4224043451 cites W3158373340 @default.
• W4224043451 cites W3158525249 @default.
• W4224043451 cites W3159191704 @default.
• W4224043451 cites W3161183609 @default.
• W4224043451 cites W3170606898 @default.
• W4224043451 cites W3173738234 @default.
• W4224043451 cites W3174607849 @default.
• W4224043451 cites W3175467532 @default.
• W4224043451 cites W3177903130 @default.
• W4224043451 cites W3179399516 @default.
• W4224043451 cites W3187192250 @default.
• W4224043451 cites W3189762432 @default.
• W4224043451 cites W3194955934 @default.
• W4224043451 cites W3198831432 @default.
• W4224043451 cites W3199542708 @default.
• W4224043451 cites W3203242093 @default.
• W4224043451 cites W3205240223 @default.
• W4224043451 cites W3215086672 @default.
• W4224043451 cites W4205199418 @default.
• W4224043451 cites W4225402540 @default.
• W4224043451 cites W4226073790 @default.
• W4224043451 cites W4226343533 @default.
• W4224043451 doi "https://doi.org/10.1016/j.vaccine.2022.04.020" @default.
• W4224043451 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35430106" @default.
• W4224043451 hasPublicationYear "2022" @default.
• W4224043451 type Work @default.
• W4224043451 citedByCount "5" @default.
• W4224043451 countsByYear W42240434512022 @default.
• W4224043451 countsByYear W42240434512023 @default.
• W4224043451 crossrefType "journal-article" @default.
• W4224043451 hasAuthorship W4224043451A5001937330 @default.
• W4224043451 hasAuthorship W4224043451A5012424809 @default.
• W4224043451 hasAuthorship W4224043451A5017174845 @default.
• W4224043451 hasAuthorship W4224043451A5032416500 @default.
• W4224043451 hasAuthorship W4224043451A5032529136 @default.
• W4224043451 hasAuthorship W4224043451A5044653763 @default.
• W4224043451 hasAuthorship W4224043451A5052451601 @default.
• W4224043451 hasAuthorship W4224043451A5060687579 @default.
• W4224043451 hasAuthorship W4224043451A5071377696 @default.
• W4224043451 hasAuthorship W4224043451A5078978544 @default.
• W4224043451 hasBestOaLocation W42240434512 @default.
• W4224043451 hasConcept C121332964 @default.
• W4224043451 hasConcept C12590561 @default.
• W4224043451 hasConcept C126322002 @default.
• W4224043451 hasConcept C1276947 @default.
• W4224043451 hasConcept C159654299 @default.
• W4224043451 hasConcept C187212893 @default.
• W4224043451 hasConcept C197934379 @default.
• W4224043451 hasConcept C203014093 @default.
• W4224043451 hasConcept C203165030 @default.
• W4224043451 hasConcept C22070199 @default.
• W4224043451 hasConcept C2779134260 @default.
• W4224043451 hasConcept C2780801004 @default.
• W4224043451 hasConcept C3007834351 @default.
• W4224043451 hasConcept C3008058167 @default.
• W4224043451 hasConcept C3018913218 @default.
• W4224043451 hasConcept C524204448 @default.
• W4224043451 hasConcept C71924100 @default.
• W4224043451 hasConceptScore W4224043451C121332964 @default.
• W4224043451 hasConceptScore W4224043451C12590561 @default.
• W4224043451 hasConceptScore W4224043451C126322002 @default.
• W4224043451 hasConceptScore W4224043451C1276947 @default.
• W4224043451 hasConceptScore W4224043451C159654299 @default.
• W4224043451 hasConceptScore W4224043451C187212893 @default.
• W4224043451 hasConceptScore W4224043451C197934379 @default.
• W4224043451 hasConceptScore W4224043451C203014093 @default.
• W4224043451 hasConceptScore W4224043451C203165030 @default.
• W4224043451 hasConceptScore W4224043451C22070199 @default.
• W4224043451 hasConceptScore W4224043451C2779134260 @default.
• W4224043451 hasConceptScore W4224043451C2780801004 @default.
• W4224043451 hasConceptScore W4224043451C3007834351 @default.

• next